Vitenskapelig artikkel

• Kverneng, Simon Ulvenes; Stige, Kjersti Eline; Berven, Haakon et al. (2025). Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease. (ekstern lenke)
• Flønes, Irene; Toker, Lilah; Sandnes, Dagny Ann et al. (2024). Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease. (ekstern lenke)
• Nido, Gonzalo Sanchez; Castelli, Martina Galatea; Mostafavi, Sepideh et al. (2024). Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies. (ekstern lenke)
• Toker, Lilah; Nido, Gonzalo Sanchez; Tzoulis, Charalampos (2023). Not every estimate counts – evaluation of cell composition estimation approaches in brain bulk tissue data. (ekstern lenke)
• Dick, Fiona; Tysnes, Ole-Bjørn; Alves, Guido Werner et al. (2023). Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson's disease. (ekstern lenke)
• Hong, Yu; Kristiansen, Cecilie Katrin; Chen, Anbin et al. (2023). POLG genotype influences degree of mitochondrial dysfunction in iPSC derived neural progenitors, but not the parent iPSC or derived glia. (ekstern lenke)
• Gaare, Johannes Jernqvist; Dölle, Christian; Brakedal, Brage et al. (2023). Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson's disease. (ekstern lenke)
• Gaare, Johannes Jernqvist; Brügger, Kim; Nido, Gonzalo Sanchez et al. (2023). DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease. (ekstern lenke)
• Brakedal, Brage; Dölle, Christian; Riemer, Frank et al. (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (ekstern lenke)
• Guitton, Romain Guillaume Bernard; Nido, Gonzalo Sanchez; Tzoulis, Charalampos (2022). No evidence of extensive non-CpG methylation in mtDNA. (ekstern lenke)
• Guitton, Romain Guillaume Bernard; Dölle, Christian; Alves, Guido Werner et al. (2022). Ultra-deep whole genome bisulfite sequencing reveals a single methylation hotspot in human brain mitochondrial DNA. (ekstern lenke)
• Toker, Lilah; Tran, Gia T.; Sundaresan, Janani et al. (2021). Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain. (ekstern lenke)
• Mostafavi, Sepideh; Balafkan, Novin; Pettersen, Ina Katrine Nitschke et al. (2021). Distinct Mitochondrial Remodeling During Mesoderm Differentiation in a Human-Based Stem Cell Model. (ekstern lenke)
• Dick, Fiona; Nido, Gonzalo Sanchez; Alves, Guido Werner et al. (2020). Differential transcript usage in the Parkinson’s disease brain. (ekstern lenke)
• Gaare, Johannes Jernqvist; Nido, Gonzalo Sanchez; Dölle, Christian et al. (2020). Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci. (ekstern lenke)
• Varhaug, Kristin Nielsen; Nido, Gonzalo Sanchez; Coo, Irenaeus de et al. (2020). Using urine to diagnose large-scale mtDNA deletions in adult patients. (ekstern lenke)
• Nido, Gonzalo Sanchez; Dick, Fiona; Toker, Lilah et al. (2020). Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition. (ekstern lenke)
• Gaare, Johannes Jernqvist; Nido, Gonzalo Sanchez; Sztromwasser, Pawel Szymon et al. (2018). Rare genetic variation in mitochondrial pathways influences the risk for parkinson's disease. (ekstern lenke)
• Nido, Gonzalo Sanchez; Dölle, Christian; Flønes, Irene Hana et al. (2018). Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease. (ekstern lenke)
• Nido, Gonzalo Sanchez; Bachschmid-Romano, Ludovica; Bastolla, Ugo et al. (2016). Learning structural bioinformatics and evolution with a snake puzzle. (ekstern lenke)
• Dölle, Christian; Flønes, Irene Hana; Nido, Gonzalo Sanchez et al. (2016). Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin

Submitted

1. Toker L, Nido GS, Tzoulis C. Not every estimate counts. (Under review Nature Neuroscience) 
2. Toker L, Tran GT, Sundaresan J, Tysnes OB, Alves G, Haugarvoll K, Nido GS, Dölle C, Tzoulis C. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain. (Under review - Molecular Neurodegeneration)
3. Gaare JJ, Nido GS, Dolle C, Sztromwasser P, Alves G, Tysnes OB, Haugarvoll K, Tzoulis C. No evidence for rare variant enrichment in Parkinson disease associated loci. (Under review - PLoS One)
4. Dick F, Nido GS, Alves G, Tysnes OB, Nilsen GH, Dölle C, Tzoulis C. Differential transcript usage in the Parkinson’s disease brain. (Accepted for publication - PLoS Genetics)

Published

1. Nido GS, Dick F, Toker L, Petersen K, Alves G, Tysnes OB, Jonassen I, Haugarvoll K, Tzoulis C. Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition. Acta Neuropathologica Communications 2020; 8(55)
2. Varhaug KN, Nido GS, de Coo R, Isohanni P, Suomalainen A, Tzoulis C, Knappskog P, Bindoff LA. Using urine to diagnose large-scale mtDNA deletions in adult patients. Annals of Clinical and Translational Neurology 2020; 7(8):1318-1326
3. Gaare JJ, Nido GS, Sztromwasser P, Knappskog P, Dahl O, Johansen ML, Grødem JM, Alves G, Tysnes OB, Johansson S, Haugarvoll H and Tzoulis C. Rare variation in biological pathways and their impact on development and progression of Parkinson’s disease. European Journal of Neurology 2019; 26:37-37
4. Gaare JJ, Nido GS, Sztromwasser P, Knappskog P, Dahl O, Johansen ML, Alves G, Tysnes OB, Johansson S, Haugarvoll H and Tzoulis C. No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson disease. Brain 2018; 141(3), e16-e19
5. Gaare JJ, Nido GS, Sztromwasser P, Knappskog P, Dahl O, Johansen ML, Grødem JM, Alves G, Tysnes OB, Johansson S, Haugarvoll H and Tzoulis C. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson disease. Movement Disorders 2018; 33(10):1591-1600
6. Nido GS, Dölle C, Flønes I, Tuppen HA, Alves G, Tysnes OB, Haugarvoll K and Tzoulis C. Ultra-deep mapping of neuronal mitochondrial deletions in Parkinson’s disease. Neurobiology of Aging 2018; 63:120-127
7. Dölle C, Flønes I, Nido GS, Miletic H, Kristoffersen S, Lilleng KP, Larsen JP, Tysness OB, Haugarvoll K, Bindoff LA, and Tzoulis C. Defective mitochondrial DNA homeostasis in the dopaminergic substantia nigra of patients with Parkinson’s disease. Nature Communications 2016; 7:13548
8. Nido GS, Bachschmid-Romano L, Bastolla U, Pascual-García A. Learning structural bioinformatics and evolution with a snake puzzle. PeerJ Computer Science, 2016;2:e100
9. Nido GS, Ryan MM, Benuskova L, and Williams J. Dynamical properties of gene regulatory networks involved in long-term potentiation. Frontiers in Molecular Neuroscience 2015;8
10. Nido GS, Williams J, Benuskova L. Bistable properties of a memory-related gene regulatory network. Neural Networks (IJCNN), IEEE 2012
11. Nido GS, Méndez R, Pascual-García A, Abia D, Bastolla U. Protein disorder in the centrosome correlates with complexity in cell types number. Molecular BioSystems 2012; 8(1):353-67
12. Pascual‐García, A., Abia, D., Méndez, R., Nido, G. S., & Bastolla, U. Quantifying the evolutionary divergence of protein structures: the role of function change and function conservation. Proteins: Structure, Function, and Bioinformatics 2010; 78(1):181-196